DE69939430D1 - Diagnose von Virus Infektion assoziierten Krebs mit Aglycoprotein 10B - Google Patents

Diagnose von Virus Infektion assoziierten Krebs mit Aglycoprotein 10B

Info

Publication number
DE69939430D1
DE69939430D1 DE69939430T DE69939430T DE69939430D1 DE 69939430 D1 DE69939430 D1 DE 69939430D1 DE 69939430 T DE69939430 T DE 69939430T DE 69939430 T DE69939430 T DE 69939430T DE 69939430 D1 DE69939430 D1 DE 69939430D1
Authority
DE
Germany
Prior art keywords
glycoconjugates
aglycoprotein
diagnosis
virus infection
associated cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69939430T
Other languages
English (en)
Inventor
Samuel Dr Bogoch
Elenore S Bogoch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69939430D1 publication Critical patent/DE69939430D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
DE69939430T 1998-09-04 1999-08-30 Diagnose von Virus Infektion assoziierten Krebs mit Aglycoprotein 10B Expired - Lifetime DE69939430D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/146,755 US6242578B1 (en) 1994-02-17 1998-09-04 Aglyco products and methods of use
PCT/US1999/019836 WO2000018351A2 (en) 1998-09-04 1999-08-30 Aglyco products and methods of use

Publications (1)

Publication Number Publication Date
DE69939430D1 true DE69939430D1 (de) 2008-10-09

Family

ID=22518867

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69939430T Expired - Lifetime DE69939430D1 (de) 1998-09-04 1999-08-30 Diagnose von Virus Infektion assoziierten Krebs mit Aglycoprotein 10B

Country Status (13)

Country Link
US (4) US6242578B1 (de)
EP (2) EP1990058A1 (de)
JP (2) JP2004515202A (de)
KR (1) KR100451446B1 (de)
CN (2) CN1328286C (de)
AT (1) ATE406175T1 (de)
AU (1) AU771836B2 (de)
BR (1) BR9913446A (de)
CA (1) CA2341763C (de)
DE (1) DE69939430D1 (de)
IL (3) IL141775A0 (de)
NZ (4) NZ510921A (de)
WO (1) WO2000018351A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7176275B2 (en) * 1998-09-04 2007-02-13 Samuel Bogoch Anthrax and small pox replikins and methods of use
DE10034712A1 (de) * 2000-07-17 2002-02-07 Arimedes Biotechnology Gmbh Verbrückte Glykokonjugate
US7894999B2 (en) 2001-03-27 2011-02-22 Samuel Bogoch Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds
US7189800B2 (en) * 2001-03-27 2007-03-13 Samuel Bogoch Replikin peptides in rapid replication of glioma cells and in influenza epidemics
EP1419175B1 (de) * 2001-03-27 2011-04-27 Samuel Dr. Bogoch Replikin-peptide und anwendungen
US7774144B2 (en) * 2001-10-26 2010-08-10 Samuel Bogoch System and method for identifying complex patterns of amino acids
US7452963B2 (en) * 2001-03-27 2008-11-18 Samuel Bogoch Replikin peptides and antibodies therefore
NZ592340A (en) * 2001-03-27 2012-12-21 Elenore S Bogoch A method for making a virus vaccine compising Replikin peptides
US7442761B2 (en) * 2003-06-06 2008-10-28 Samuel Bogoch Replikin peptides and uses thereof
US7420028B2 (en) 2001-03-27 2008-09-02 Samuel Bogoch Replikins and methods of identifying replikin-containing sequences
KR101067654B1 (ko) 2001-07-09 2011-09-26 엘레노어 에스 보고치 레플리킨 펩타이드 및 그의 이용
JP2006500001A (ja) * 2001-07-09 2006-01-05 ボゴーク，サミュエル レプリキンペプチドとその使用
US7306919B1 (en) 2001-10-31 2007-12-11 Thornthwaite Jerry T Antigen-antibody cancer recognition system
US8603345B2 (en) * 2003-02-13 2013-12-10 Becton, Dickinson And Company Devices for component removal during blood collection, and uses thereof
US8494781B2 (en) 2003-06-06 2013-07-23 Samuel Bogoch Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
US9254315B2 (en) 2004-04-28 2016-02-09 Samuel Bogoch Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
US9002652B1 (en) * 2005-01-27 2015-04-07 Institute For Systems Biology Methods for identifying and using organ-specific proteins in blood
CA2598381A1 (en) 2005-02-16 2006-08-24 Samuel Bogoch Replikin peptides and uses thereof
US9820986B2 (en) * 2005-03-04 2017-11-21 Taiwan Hopaz Chems, Mfg. Co., Ltd. Glycopeptide compositions
JP2006288670A (ja) * 2005-04-11 2006-10-26 Terumo Corp カテーテル
EP2092059A4 (de) * 2006-10-24 2012-03-28 Bogoch Samuel Verfahren zur vorhersage von influenza-ausbrüchen durch korrelation eines erhöhten replikin-spiegels in white-spot- und/oder taura-viren bei krabben
US20090017052A1 (en) * 2007-01-18 2009-01-15 Samuel Bogoch Methods of determining lethality of pathogens and malignancies involving replikin peak genes
US20100105634A1 (en) * 2007-03-07 2010-04-29 Cargill, Incorporated Use of glucosamine as a mental and physical stress recovery enhancer and a performance enhancer
US9408902B2 (en) * 2007-05-30 2016-08-09 Samuel Bogoch Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture
US20090269367A1 (en) * 2008-04-23 2009-10-29 Samuel Bogoch Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
US20100144589A1 (en) * 2008-08-08 2010-06-10 Samuel Bogoch Methods of predicting cancer lethality using replikin counts
US9233148B2 (en) 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
US9320784B2 (en) 2009-08-07 2016-04-26 Samuel Bogoch Peptides shared among lethal cancers and therapeutic compositions comprising said peptides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4298590A (en) * 1975-02-25 1981-11-03 Samuel Bogoch Detection of malignant tumor cells
US4840915A (en) * 1975-02-25 1989-06-20 Brain Research, Inc. Method for diagnosing malignant tumors
US4041146A (en) * 1975-05-01 1977-08-09 General Electric Company Method for detection of biological particles
US4486538A (en) * 1978-07-07 1984-12-04 Samuel Bogoch Detection of malignant tumor cells
US5280113A (en) 1989-08-16 1994-01-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
GB9202219D0 (en) 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
AU2289195A (en) * 1995-04-11 1996-10-30 Elenore S. Bogoch Aglyco products

Also Published As

Publication number Publication date
IL192679A0 (en) 2009-02-11
IL192679A (en) 2011-10-31
US20080241859A1 (en) 2008-10-02
EP1990058A1 (de) 2008-11-12
CN1324258A (zh) 2001-11-28
JP2011087589A (ja) 2011-05-06
CA2341763C (en) 2014-01-21
NZ556151A (en) 2009-03-31
CN101096382A (zh) 2008-01-02
CN1328286C (zh) 2007-07-25
NZ533511A (en) 2006-08-31
NZ510921A (en) 2004-09-24
ATE406175T1 (de) 2008-09-15
WO2000018351A2 (en) 2000-04-06
US7381411B2 (en) 2008-06-03
AU771836B2 (en) 2004-04-01
CA2341763A1 (en) 2000-04-06
US6638505B2 (en) 2003-10-28
AU5698699A (en) 2000-04-17
KR100451446B1 (ko) 2004-10-06
EP1115418B1 (de) 2008-08-27
EP1115418A4 (de) 2004-06-09
KR20010072517A (ko) 2001-07-31
NZ544362A (en) 2008-05-30
EP1115418A2 (de) 2001-07-18
US20030023047A1 (en) 2003-01-30
BR9913446A (pt) 2004-03-02
IL141775A0 (en) 2002-03-10
IL141775A (en) 2008-11-26
WO2000018351A3 (en) 2000-07-13
JP2004515202A (ja) 2004-05-27
US6242578B1 (en) 2001-06-05
US20040077532A1 (en) 2004-04-22

Similar Documents

Publication Publication Date Title
DE69939430D1 (de) Diagnose von Virus Infektion assoziierten Krebs mit Aglycoprotein 10B
DK0835133T3 (da) Rekombinant koppevirus-rabies-præparater og kombinationspræparater samt anvendelser deraf
ATE283289T1 (de) Monoklonale antikörper, antigene sowie diagnose und therapie von bösartigen krankheiten
BRPI0010612B8 (pt) vacinas
BR0112542A (pt) Composições e métodos papa a terapia e a diagnose de câncer ovariano
DE69030172T2 (de) Impfstoffe gegen Krebs und Infektionskrankheiten
EP0372501A3 (de) Synthetische Antigene, Verfahren zu ihrer Herstellung und ihre Verwendung
WO1998008542A3 (en) Compounds and methods for treatment and diagnosis of mycobacterial infections
BR9814487A (pt) "vacina"
SE8604007L (sv) Vaccin och immunoanalyser for forvervat immunbristsyndrom (aids)
GB2255093A (en) Hiv-1 core protein fragments
ATE170220T1 (de) Zusammensetzung verwendbar als therapeutisches mittel gegen chronische virale leberkrankheiten
EP0090581A3 (de) Kleine, für Maul- und Klauenseuche spezifische Peptide
ES2170152T3 (es) Virus de la hepatitis g y clon molecular del mismo.
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
DE60125537D1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
ATE407209T1 (de) Cryptosporidium parvum antigene, deren antikörper und deren diagnostische und medische verbindungen
DE60036692D1 (de) Zusammensetzungen und methoden zur detektion einer trypanosoma cruzi infektion
EP1572721A4 (de) Prävention und behandlung von hcv-infektionen unter anwendung von gegen konformationelle und lineare epitope gerichteten antikörpern
ATE142262T1 (de) Gegen das menschliche immunschwäche-virus gerichtetes immunpräparat
Jamasbi et al. Detection of circulating tumor antigens in mice carrying a highly metastatic pulmonary squamous‐cell carcinoma
SE8803062D0 (sv) Sequential polypeptides endowed with immunological activity
RU95121622A (ru) Усовершенствованный способ лечения синдрома приобретенного иммунного дефицита (спид)
Bagherwal et al. Immune response modulation to DPT (Diph-theria, Pertussis, Tetanus) vaccine by NDL from Calotropis procera
RU2001127052A (ru) Штамм вируса Эбола "Заир Ч-15" для проведения модельных экспериментов и приготовления диагностических и вакцинных препаратов

Legal Events

Date Code Title Description
8364 No opposition during term of opposition